5 Best Pharma Stocks To Buy Now

In this article, we discuss the 5 best pharma stocks to buy now. You can go through our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 11 Best Pharma Stocks To Buy Now.

5. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 73

Pfizer Inc. (NYSE:PFE) is a U.S.-based multinational pharmaceutical and biotechnology corporation, with its headquarters located at The Spiral in Manhattan, New York City. Established in 1849 by German entrepreneurs Charles Pfizer and Charles F. Erhart, the company is renowned for its research, development, and production of medicines and vaccines across a wide spectrum of medical fields, encompassing immunology, oncology, cardiology, endocrinology, and neurology. Particularly noteworthy, in 2022, Pfizer Inc. (NYSE:PFE)’s standout product was the COVID-19 vaccine Comirnaty, which generated an impressive $37.8 billion in alliance revenues and direct sales.

The U.S. Food and Drug Administration (FDA) has granted approval for Pfizer Inc. (NYSE:PFE)’s vaccine, known as Penbraya, marking the first vaccine capable of safeguarding against five distinct categories of life-threatening bacteria responsible for conditions such as meningitis and blood poisoning. Pfizer Inc. (NYSE:PFE) presently offers two vaccines for the prevention of this disease.

As of the close of Q2 2023, 73 hedge funds in Insider Monkey’s database owned stakes in Pfizer Inc. (NYSE:PFE), which remained unchanged from the previous quarter. These stakes have a total worth of over $1.5 billion. With roughly 7 million shares, Diamond Hill Capital was the company’s leading stakeholder in Q2.